Sigyn Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SIGY research report →
Price Chart
About the company
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders.
- CEO
- James A. Joyce
- IPO
- 2021
- Employees
- 4
- HQ
- San Diego, CA, US
Get TickerSpark's AI analysis on SIGY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $52.98K
- P/E
- -0.02
- Fwd P/E
- 0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.01
- EV/EBITDA
- -1.25
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 57.73%
- ROIC
- 37.61%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-1,363+75.7%
- Op Income
- $-1,785,887
- Net Income
- $-3,363,925-0.7%
- EPS
- $-2.09+16.7%
- OCF Growth
- +2.3%
- FCF Growth
- +2.3%
- 52W High
- $3.00
- 52W Low
- $0.01
- 50D MA
- $0.03
- 200D MA
- $0.26
- Beta
- -0.06
- RSI (14)
- 51
- Avg Volume
- 14.16K
No earnings-call transcripts are available for SIGY yet.
- Free Float
- 55.4%
- Shares Outstanding
- 5.40M
- Float Shares
- 889.17K
Our SIGY coverage
Recent articles, reports, and earnings notes.
No research on SIGY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SIGY report →Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
globenewswire.com · May 7
Head-To-Head Analysis: Sigyn Therapeutics (OTCMKTS:SIGY) vs. Shuttle Pharmaceuticals (NASDAQ:SHPH)
defenseworld.net · Apr 17
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
newsfilecorp.com · Oct 21
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
newsfilecorp.com · Oct 17
Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
globenewswire.com · Sep 16
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
accessnewswire.com · Jul 1
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
accessnewswire.com · Jul 1
Sigyn Therapeutics to Present at Tomorrow's Small Cap Growth Virtual Investor Conference
globenewswire.com · Feb 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.